Company / R&D Expense
VYCOR MEDICAL INC R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$10.0K
FY2025
5-year range
$10.0K / $22.6K
FY2021-FY2025
Trend
-35.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $22,558 to $9,963 over the past 2 years.
Based on SEC 10-K filings.
$9,963 in FY2025.
Declined from $22,558 to $9,963 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d expense decreased 35.0% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.0K | -35.0% |
| FY2024 | $15.3K | -32.1% |
| FY2023 | $22.6K | - |
| FY2022 | - | - |
| FY2021 | $15.2K | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | $3.0K | -36.4% |
| FY2016 | $4.7K | -93.1% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026